‘He financed a brand-new car in his name for me — it cost over $45,000. I made aggressive payments every month and even took money from my 401(k) to pay off the car.’
Novavax Inc. has delayed plans to seek regulatory clearances for its COVID-19 vaccine, while shortages in raw materials are slowing the ramp-up of production of doses, the company said.